Intervention on Conference Room Paper: Concrete actions to address PCB decision points related to civil society
Delivered by Rani Ravudi, Asia and the Pacific NGO Delegate
The Delegation thanks the Secretariat for the Conference paper and appreciates its work in undertaking the initial monitoring of the implementation of the Decision Points (DPs) pertaining to civil society. While being cognizant of the scope and limitations of the assessment, we would like to register that there is a need to provide as much information that is available, in order to have a fair and clear picture of the results and impact of the DPs.
The report gives an overview of all that is being done related to the topics raised in the DPs, but it does not clearly show if the DPs themselves were specifically acted on, whether they addressed the issues they referred to, and what the outcomes were.As mentioned in the Scope of the Review, there are actions taken by either a Cosponsor or the Secretariat were not necessarily undertaken to address one specific DP related to civil society. This begs the question of attribution versus contribution in many cases.
Our Latin America and the Caribbean NGO Delegates and colleagues are holding two calls (one in Spanish and one in English) for civil society partners and friends from any region to join, discuss topics and agenda items, and provide feedback from the ground.
The following are highlights of discussions during the global civil society calls in preparation for the 34th UNAIDS PCB Meeting. Even though the participation was diverse, many common elements were raised and discussed from all around the world. This year, 3 calls were held bringing together diverse representations and NGO Delegation members: 1) Africa/Asia and the Pacific/Europe; 2) Americas (English); 3) Americas (Spanish).
Deadline: November 30, 2012
The Global Alliance for TB Drug Development (TB Alliance) is a not-for-profit product development partnership accelerating the discovery and development of new tuberculosis (TB) drugs that will shorten treatment, be effective against drug susceptible and drug resistant strains, be compatible with antiretroviral therapies for HIV and improve treatment of latent infection. Working with public and private research organizations worldwide, the TB Alliance is leading the advancement of the largest portfolio of TB drug candidates in history, paving the way for the first new treatments in over 40 years. The TB Alliance is committed to ensuring that approved new regimens are affordable, adopted and available to those who need them.
UNAIDS was the first ever United Nations programme to have civil society formally represented on its governing body – the Programme Coordinating Board (PCB). The NGO Delegation has 10 members from five geographic regions.
Deadline: 12 October 2012
Photo: Auntie P
The UN Special Rapporteur on the right to health invites civil society to take part in the online consultation on access to medicines. Pursuant the Human Rights Council resolution 17/14, the Special Rapporteur is working on a study on existing challenges with regard to access to medicines in the context of the right to health, ways to overcome them and good practices, to be presented to the Council at its twenty-third session in June 2013.
In light of its new approach to funding grants, the Global Fund to Fight AIDS, Tuberculosis and Malaria has published an information note on how the institution will now engage with civil society. The note contains information on the restructuring, how civil society can engage under its new structure and an annex of key staff members you can contact. The document is available in English and French.
The recently launched Robert Carr civil society Networks Fund seeks to provide a more sustainable funding stream that will address key gaps in resourcing needs of global and regional civil society and community networks through providing funding for: